These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 36694432)

  • 21. Agonist concentration-dependent differential responsivity of a human platelet purinergic receptor: pharmacological and kinetic studies of aggregation, deaggregation and shape change responses mediated by the purinergic P2Y1 receptor in vitro.
    Maayani S; Schwarz TE; Patel ND; Craddock-Royal BD; Tagliente TM
    Platelets; 2003; 14(7-8):445-62. PubMed ID: 14713514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aspirin-Dependent Effects on Purinergic P2Y1 Receptor Expression.
    Massimi I; Alemanno L; Guarino ML; Guerriero R; Mancone M; Ceccacci A; Frati L; Angiolillo DJ; Pulcinelli FM
    Thromb Haemost; 2019 May; 119(5):726-734. PubMed ID: 30759486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of different regression models for the quantitative analysis of the combined effect of P2Y
    Watala C; Wzorek J; Palma A; Boncler M
    Thromb Res; 2022 Mar; 211():88-97. PubMed ID: 35134667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet P2Y
    Amoafo EB; Entsie P; Kang Y; Canobbio I; Liverani E
    Br J Pharmacol; 2024 Feb; 181(4):532-546. PubMed ID: 37525937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential involvement of the P2Y1 and P2YT receptors in the morphological changes of platelet aggregation.
    Eckly A; Gendrault JL; Hechler B; Cazenave JP; Gachet C
    Thromb Haemost; 2001 Apr; 85(4):694-701. PubMed ID: 11341507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ATP derivatives are antagonists of the P2Y1 receptor: similarities to the platelet ADP receptor.
    Hechler B; Vigne P; Léon C; Breittmayer JP; Gachet C; Frelin C
    Mol Pharmacol; 1998 Apr; 53(4):727-33. PubMed ID: 9547364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of clopidogrel administration to healthy volunteers on platelet phosphorylation events triggered by ADP.
    Contreres JO; Dupuy E; Job B; Habib A; Bryckaert M; Rosa JP; Simoneau G; Herbert JM; Savi P; Levy-Toledano S
    Br J Haematol; 2003 Feb; 120(4):633-42. PubMed ID: 12588350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostaglandin E1 potentiates the effects of P2Y12 blockade on ADP-mediated platelet aggregation in vitro: Insights using short thromboelastography.
    Khanna V; Armstrong PC; Warner TD; Curzen N
    Platelets; 2015; 26(7):689-92. PubMed ID: 25734957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for a PI3-kinase independent pathway in the regulation of Rap1b activation downstream of the P2Y12 receptor in platelets.
    Dangelmaier C; Kunapuli SP
    Platelets; 2022 Nov; 33(8):1301-1306. PubMed ID: 35514261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antipsychotic Drugs Inhibit Platelet Aggregation via P2Y 1 and P2Y 12 Receptors.
    Wu CC; Tsai FM; Chen ML; Wu S; Lee MC; Tsai TC; Wang LK; Wang CH
    Biomed Res Int; 2016; 2016():2532371. PubMed ID: 27069920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet Purinergic Receptors in Thrombosis and Inflammation.
    Gachet C; Hechler B
    Hamostaseologie; 2020 May; 40(2):145-152. PubMed ID: 32464678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of platelet P2Y
    Parker WAE; Storey RF
    Br J Pharmacol; 2024 Feb; 181(4):515-531. PubMed ID: 37771103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Calmodulin interacts with the platelet ADP receptor P2Y1.
    Arthur JF; Shen Y; Mu FT; Leon C; Gachet C; Berndt MC; Andrews RK
    Biochem J; 2006 Sep; 398(3):339-43. PubMed ID: 16848759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modified diadenosine tetraphosphates with dual specificity for P2Y1 and P2Y12 are potent antagonists of ADP-induced platelet activation.
    Chang H; Yanachkov IB; Dix EJ; Li YF; Barnard MR; Wright GE; Michelson AD; Frelinger AL
    J Thromb Haemost; 2012 Dec; 10(12):2573-80. PubMed ID: 23083103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lineage-specific overexpression of the P2Y1 receptor induces platelet hyper-reactivity in transgenic mice.
    Hechler B; Zhang Y; Eckly A; Cazenave JP; Gachet C; Ravid K
    J Thromb Haemost; 2003 Jan; 1(1):155-63. PubMed ID: 12871553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Benzoyl ATP is an antagonist of rat and human P2Y1 receptors and of platelet aggregation.
    Vigne P; Hechler B; Gachet C; Breittmayer JP; Frelin C
    Biochem Biophys Res Commun; 1999 Mar; 256(1):94-7. PubMed ID: 10066429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. On the mechanism of plasmin-induced platelet aggregation. Implications of the dual role of granule ADP.
    Ishii-Watabe A; Uchida E; Mizuguchi H; Hayakawa T
    Biochem Pharmacol; 2000 Jun; 59(11):1345-55. PubMed ID: 10751543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A differential role of the platelet ADP receptors P2Y1 and P2Y12 in Rac activation.
    Soulet C; Hechler B; Gratacap MP; Plantavid M; Offermanns S; Gachet C; Payrastre B
    J Thromb Haemost; 2005 Oct; 3(10):2296-306. PubMed ID: 16194206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antagonism of P2Y1-induced vasorelaxation by acyl CoA: a critical role for palmitate and 3'-phosphate.
    Alefishat E; Alexander SP; Ralevic V
    Br J Pharmacol; 2013 Apr; 168(8):1911-22. PubMed ID: 23215951
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New highly active antiplatelet agents with dual specificity for platelet P2Y1 and P2Y12 adenosine diphosphate receptors.
    Yanachkov IB; Chang H; Yanachkova MI; Dix EJ; Berny-Lang MA; Gremmel T; Michelson AD; Wright GE; Frelinger AL
    Eur J Med Chem; 2016 Jan; 107():204-18. PubMed ID: 26588064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.